# FDA recall D-0332-2021

> **Lupin Pharmaceuticals Inc.** · Class II · drug recall initiated 2021-03-26.

## Product

Cefprozil for Oral Suspension USP, 250mg/5mL, packaged as a) 50 mL (when mixed) bottles (NDC 68180-402-01); b) 75 mL (when mixed) bottles (NDC 68180-402-02); and c) 100 mL (when mixed) bottles (NDC 68180-402-03); Rx only, Manufactured for: Lupin Pharmaceutical, Inc., Baltimore, MD  21202; Manufactured by: Lupin Limited, Mandideep 462 046, India.

## Reason for recall

Superpotent Drug

## Distribution

Nationwide in the USA and Puerto Rico

## Key facts

- **Recall number:** D-0332-2021
- **Recalling firm:** Lupin Pharmaceuticals Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-03-26
- **Report date:** 2021-04-21
- **Termination date:** 2021-12-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Baltimore, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0332-2021

## Citation

> AI Analytics. FDA recall D-0332-2021. Retrieved 2026-08-11 from https://api.ai-analytics.org/recall/D-0332-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*